Company Profile

490 Biotech Inc
Profile last edited on: 10/31/22      CAGE: 6H7R3      UEI: L2T9XGZ1JUL5

Business Identifier: Bio-luminescent human cell lines for data acquisition without substrate.
Year Founded
2011
First Award
2013
Latest Award
2020
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

2450 E J Chapman Drive
Knoxville, TN 37996
   (865) 974-9605
   info@490biotech.com
   www.490biotech.com
Location: Single
Congr. District: 02
County: Knox

Public Profile

490 BioTech is a life sciences company developing patented protected light-emitting (bioluminescent) human cell lines genetically programmed to ‘report’ on biological events or interactions that affect their metabolic status. The firm's autobioluminescent technologies enable cells autonomously to control or continuously produce light without any external activation required. The Clinet User can choose pre-made, continuously luminescent human cell models, ready-to-use assay mixes that can make any cell glow for up to one week, robust, yeast-based environmental sensor kits, or custom solutions allow the User to garner more information with less cost and effort than ever before. The incorporation of these cell lines into cell culture and small animal preclinical efficacy/toxicity testing models does not require expensive substrates and as such is designed to accelerate the pace of new drug discovery and move drugs more rapidly and effectively towards Phase I human test

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Key People / Management

  Gary S Sayler -- CEO

  Dan Close -- Co-Founder and Chief Scientific Officer

  Dan Morrison

  Stacey Patterson -- CTO

  Steven Ripp -- COO

  Mark Wienhold -- Research Scientist